PierianDx aims to improve diagnosis for chronic disease, including cancer

PierianDx aims to democratise clinical next-generation sequencing. By making precision medicine more accessible they want to improve the overall healthcare output.

In 2003, Washington University made the first-ever breakthrough of mapping the first human genome. Years later in 2011, the University was able to successfully create Clinical Genomics Workspace (CGW), a kind of software specifically made for clinical genomics. It streamlines and provides accurate analysis and conclusions of medical programs. 

Soon Washington University made a technology transfer to Rakesh Nagarajan’s budding venture PierianDx in 2014. PierianDx’s first solution was in collaboration with the University’s Department of Pathology & Immunology and Genetics. The University was the first one to acknowledge and validate next-generation clinical sequencing. 

PierianDx aims to democratise clinical next-generation sequencing. They work towards improving diagnosis for chronic disease, including cancer, and creating targeted treatments for the patients. By making precision medicine more accessible they want to improve the overall healthcare output. 

The startup received instant success. By 2015, they had received 14.2 million in its Series A round. Some of its investors are Health Catalyst Capital, Inova Health Systems, RTI International and ARUP Laboratories. In 2016, they opened their office in Pune to advance and develop their software. Within four years of their establishment, they had gained 40+ customers. In 2019, they partnered with the industry leader Illumina. 

ATW Partners and SJF Ventures raised an additional $27 million in 2019. Their post-money valuation was in the range of $100-500 million in the same year. By the end of 2019, PierianDx had expanded into Asia Pacific, Europe and the Middle East. They now collaborate with 100 plus clinical institutions.

Will the company achieve their dream of democratising next-generation sequencing a reality for every Indian? The company currently faces the challenge of making genomic testing with reduced cost and with a better turnaround time. This is slowing down the pace of adoption in India’s healthcare sector. Affordability is the biggest hurdle any health-tech company faces when it comes to popularizing it to the masses.

Tags : #PierianDx #RakeshNagarajan #next-generationsequencing #WashingtonUniversity #Illumina #cancerdiagnosis #personalisedtreatment #smitakumar #medicircle

Related Stories

Loading Please wait...


Trending Now

How a Fiber-Rich Diet and Gut Parasites Can Improve Your HealthJuly 16, 2024
LinkedIn: A Double-Edged Sword for Professional GrowthJuly 16, 2024
Food Safety and Drug Administration (FDA), Uttarakhand, National Association of Street Vendors of India (NASVI) and Nestlé India expand Project ‘Serve Safe Food’ in Uttarakhand July 16, 2024
IIT Kharagpur and University of Leeds Sign MoU for Joint Supervision of PhD ProgramsJuly 16, 2024
Puja Curtains go up with KHUTI PUJA at Hazra Park DurgotsabJuly 16, 2024
Algorand and SEWA Join Forces to Launch Digital Health Passport Initiative for Women's EmpowermentJuly 15, 2024
The Debate Over Menstrual Leave: Balancing Needs and Workplace EqualityJuly 15, 2024
Young Indians Face Higher Lung Cancer Risk: Insights and ImplicationsJuly 15, 2024
Honoring a Healthcare Pioneer: Indian-origin Dr. George Matthew's Legacy in the UAEJuly 15, 2024
The Role of Platelets and Monocytes: New Research InsightsJuly 13, 2024
Groundbreaking Discovery in Cancer Research: Over 5,000 Genetic Variations IdentifiedJuly 13, 2024
June 2024: The Hottest Month on Record and What It Means for Our PlanetJuly 13, 2024
Cambodia Angkor Air teams up with Çelebi India for Cargo OperationsJuly 12, 2024
Empowering Consumers with Nutritional Information: FSSAI's New Labeling GuidelinesJuly 12, 2024
Innovative Migraine Research Uncovers Key Triggers and Pathways for PainJuly 12, 2024
Alarming Rise in Death's Due to HIV Among Students in Tripura: Urgent Need for ActionJuly 12, 2024
Amrita Vishwa Vidyapeetham is All Set to Produce Netravaad, an Innovative Technology for Speech Impairment July 11, 2024
Twice-Yearly Injection Shows 100% HIV Protection in Young WomenJuly 11, 2024
AIMS (Asian Hospital) Doctors Restore Disfigured Face of Road Accident VictimJuly 10, 2024